BCIQ Profiles

Company Profile Report

Leo Pharma invests in PellePharm to develop rare skin disease therapy

Dermatology company Leo Pharma A/S (Ballerup, Denmark) gained an option to acquire PellePharm Inc. (Menlo Park, Calif.) and will help fund development of PellePharm's patidegib to

Read the full 267 word article

How to gain access

Continue reading with a
two-week free trial.